The Globalization Debate:
Factors in Drug Costs & Pricing
| Event Details |
| 12-7 pm |
January 11, 2007 |
| |
Tuck School of Business |
Conference Overview
Tuck's first annual healthcare conference examined the impact of globalization on the pharmaceutical and biotechnology ("biopharma") industries. Biopharma companies increasingly are searching the world both for new markets and for opportunities to reduce drug development costs. The conference addressed questions of how globalization is changing the pricing and sourcing decisions of biopharma companies and the structure of the companies themselves.
Biopharma companies operate in a world where payment systems can vary dramatically by country. Is this situation sustainable in the face of increased integration among economies and societies across the globe? How might payment systems change over time?
In the race to develop new drugs, do global companies have a competitive edge? How can companies leverage emerging countries to reduce drug development costs? Is the industry headed for a truly global model of development and production? What unique barriers might companies face in attempting to offshore product development and what are the prospects for this type of activity in the future?
